Description
Etrotab-90 | Etoricoxib 90mg Tablets
It is an Etoricoxib 90mg tablet by Arrowin Pharmaceuticals, prescribed for moderate to severe joint pain and inflammation in patients with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. It is the higher-strength formulation in the Etrotab range, indicated when lower-dose Etoricoxib has not provided adequate symptom control or when the clinical condition demands stronger anti-inflammatory coverage from the start.
Etoricoxib is a selective COX-2 inhibitor. It works by blocking the enzyme responsible for producing prostaglandins that drive inflammation and pain at the joint level, while leaving the COX-1 enzyme largely unaffected. COX-1 is what protects the gastric lining, and this is precisely why Etoricoxib is better tolerated in the stomach than conventional NSAIDs like Ibuprofen or Diclofenac, which block both enzymes indiscriminately. For patients who need sustained anti-inflammatory therapy over weeks or months, this distinction matters.
Once-daily dosing at 90mg maintains consistent drug levels throughout the 24-hour period, delivering uninterrupted control of inflammation without the peaks and troughs of shorter-acting pain medications. Orthopaedic surgeons and rheumatologists also prescribe Etrotab-90 for acute gouty arthritis, where rapid and effective control of joint inflammation is the clinical priority.
Composition
Each tablet contains Etoricoxib IP 90mg.
Therapeutic Class
Selective COX-2 Inhibitor and Non-Steroidal Anti-Inflammatory Drug.
Indications
It is indicated for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis and moderate to severe acute musculoskeletal pain where higher-potency COX-2 inhibitor therapy is clinically appropriate.
Dosage and Administration
One tablet once daily, taken with or after food. Duration should be the shortest clinically necessary period. Always follow the prescribing physician’s instructions on dose and duration.
Packaging
10×15 ALU-ALU.
Are There Any Side Effects of Etrotab-90?
Etrotab-90 is generally well tolerated. Some patients may experience nausea, heartburn, headache or mild dizziness, which are usually transient. With prolonged use, COX-2 inhibitors carry cardiovascular risks, including fluid retention and elevated blood pressure, consistent with the class effect of all selective COX-2 inhibitors. Etrotab-90 is contraindicated in patients with established heart disease, uncontrolled hypertension or a history of significant gastrointestinal bleeding. Always use at the lowest effective dose for the shortest necessary duration under physician supervision.
FAQs
What is Etrotab-90 used for?
It is an Etoricoxib 90mg tablet prescribed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis. It provides potent once-daily relief from joint pain, swelling, and inflammation in patients who require higher-strength COX-2 inhibitor therapy.
What is the difference between Etrotab-60 and Etrotab-90?
Both contain Etoricoxib as the active ingredient. Etrotab-60 is suited for milder inflammatory conditions and patients requiring moderate anti-inflammatory coverage. Etrotab-90 delivers a stronger and more sustained anti-inflammatory effect, making it appropriate for more advanced arthritis, acute gout and cases where the 60mg dose has not provided sufficient symptom control. The treating physician determines which strength is appropriate based on the patient’s condition and clinical response.
Why is Etoricoxib preferred over conventional NSAIDs for arthritis?
Conventional NSAIDs inhibit both COX-1 and COX-2 enzymes. COX-1 protects the gastric lining, so blocking it raises the risk of ulcers and gastrointestinal bleeding with prolonged use. Etoricoxib selectively targets COX-2, thereby delivering equivalent anti-inflammatory efficacy with significantly lower gastric risk. This makes it a better long-term option for patients with arthritis who need sustained anti-inflammatory therapy.
Can Etrotab-90 be taken long-term?
Etoricoxib 90mg should be used at the lowest effective dose for the shortest necessary duration. For chronic arthritis management, the physician should regularly reassess the need for continued therapy and monitor blood pressure, renal function and cardiovascular status with prolonged use.
Is Etrotab-90 available for PCD Pharma Franchise?
Yes, it is available for PCD distribution with monopoly rights across territories. Contact Arrowin Pharmaceuticals to discuss franchise opportunities in your region.
Explore the complete Etrotab range for targeted pain and inflammation management: View All Etrotab Products
